Global Infectious Bursal Disease Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Infectious Bursal Disease Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Infectious Bursal Disease Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Infectious Bursal Disease Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Infectious Bursal Disease Vaccine Segment by Type

2.2.1 Live

2.2.2 Inactivated

2.3 Infectious Bursal Disease Vaccine Sales by Type

2.3.1 Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Infectious Bursal Disease Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Infectious Bursal Disease Vaccine Sale Price by Type (2017-2022)

2.4 Infectious Bursal Disease Vaccine Segment by Application

2.4.1 Veterinary Pharmacy

2.4.2 Online Sale

2.4.3 Others

2.5 Infectious Bursal Disease Vaccine Sales by Application

2.5.1 Global Infectious Bursal Disease Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Infectious Bursal Disease Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Infectious Bursal Disease Vaccine Sale Price by Application (2017-2022)

3 Global Infectious Bursal Disease Vaccine by Company

3.1 Global Infectious Bursal Disease Vaccine Breakdown Data by Company

3.1.1 Global Infectious Bursal Disease Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Infectious Bursal Disease Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Infectious Bursal Disease Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Infectious Bursal Disease Vaccine Revenue by Company (2020-2022)

3.2.2 Global Infectious Bursal Disease Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Infectious Bursal Disease Vaccine Sale Price by Company

3.4 Key Manufacturers Infectious Bursal Disease Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Infectious Bursal Disease Vaccine Product Location Distribution

3.4.2 Players Infectious Bursal Disease Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Infectious Bursal Disease Vaccine by Geographic Region

4.1 World Historic Infectious Bursal Disease Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Infectious Bursal Disease Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Infectious Bursal Disease Vaccine Annual Revenue by Geographic Region

4.2 World Historic Infectious Bursal Disease Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Infectious Bursal Disease Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Infectious Bursal Disease Vaccine Annual Revenue by Country/Region

4.3 Americas Infectious Bursal Disease Vaccine Sales Growth

4.4 APAC Infectious Bursal Disease Vaccine Sales Growth

4.5 Europe Infectious Bursal Disease Vaccine Sales Growth

4.6 Middle East & Africa Infectious Bursal Disease Vaccine Sales Growth

5 Americas

5.1 Americas Infectious Bursal Disease Vaccine Sales by Country

5.1.1 Americas Infectious Bursal Disease Vaccine Sales by Country (2017-2022)

5.1.2 Americas Infectious Bursal Disease Vaccine Revenue by Country (2017-2022)

5.2 Americas Infectious Bursal Disease Vaccine Sales by Type

5.3 Americas Infectious Bursal Disease Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Infectious Bursal Disease Vaccine Sales by Region

6.1.1 APAC Infectious Bursal Disease Vaccine Sales by Region (2017-2022)

6.1.2 APAC Infectious Bursal Disease Vaccine Revenue by Region (2017-2022)

6.2 APAC Infectious Bursal Disease Vaccine Sales by Type

6.3 APAC Infectious Bursal Disease Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Infectious Bursal Disease Vaccine by Country

7.1.1 Europe Infectious Bursal Disease Vaccine Sales by Country (2017-2022)

7.1.2 Europe Infectious Bursal Disease Vaccine Revenue by Country (2017-2022)

7.2 Europe Infectious Bursal Disease Vaccine Sales by Type

7.3 Europe Infectious Bursal Disease Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Infectious Bursal Disease Vaccine by Country

8.1.1 Middle East & Africa Infectious Bursal Disease Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Infectious Bursal Disease Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Infectious Bursal Disease Vaccine Sales by Type

8.3 Middle East & Africa Infectious Bursal Disease Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Infectious Bursal Disease Vaccine

10.3 Manufacturing Process Analysis of Infectious Bursal Disease Vaccine

10.4 Industry Chain Structure of Infectious Bursal Disease Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Infectious Bursal Disease Vaccine Distributors

11.3 Infectious Bursal Disease Vaccine Customer

12 World Forecast Review for Infectious Bursal Disease Vaccine by Geographic Region

12.1 Global Infectious Bursal Disease Vaccine Market Size Forecast by Region

12.1.1 Global Infectious Bursal Disease Vaccine Forecast by Region (2023-2028)

12.1.2 Global Infectious Bursal Disease Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Infectious Bursal Disease Vaccine Forecast by Type

12.7 Global Infectious Bursal Disease Vaccine Forecast by Application

13 Key Players Analysis

13.1 Zoetis

13.1.1 Zoetis Company Information

13.1.2 Zoetis Infectious Bursal Disease Vaccine Product Offered

13.1.3 Zoetis Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Zoetis Main Business Overview

13.1.5 Zoetis Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Infectious Bursal Disease Vaccine Product Offered

13.2.3 Merck Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 Elanco

13.3.1 Elanco Company Information

13.3.2 Elanco Infectious Bursal Disease Vaccine Product Offered

13.3.3 Elanco Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Elanco Main Business Overview

13.3.5 Elanco Latest Developments

13.4 Boehringer Ingelheim

13.4.1 Boehringer Ingelheim Company Information

13.4.2 Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Offered

13.4.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Boehringer Ingelheim Main Business Overview

13.4.5 Boehringer Ingelheim Latest Developments

13.5 Ceva

13.5.1 Ceva Company Information

13.5.2 Ceva Infectious Bursal Disease Vaccine Product Offered

13.5.3 Ceva Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Ceva Main Business Overview

13.5.5 Ceva Latest Developments

13.6 Qingdao Yibang Biological Engineering Co., Ltd.

13.6.1 Qingdao Yibang Biological Engineering Co., Ltd. Company Information

13.6.2 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Offered

13.6.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Qingdao Yibang Biological Engineering Co., Ltd. Main Business Overview

13.6.5 Qingdao Yibang Biological Engineering Co., Ltd. Latest Developments

13.7 Shandong Lvdu Biological Technology Co., Ltd.

13.7.1 Shandong Lvdu Biological Technology Co., Ltd. Company Information

13.7.2 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Offered

13.7.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Shandong Lvdu Biological Technology Co., Ltd. Main Business Overview

13.7.5 Shandong Lvdu Biological Technology Co., Ltd. Latest Developments

13.8 Plyco Bioengineering Co., Ltd.

13.8.1 Plyco Bioengineering Co., Ltd. Company Information

13.8.2 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Offered

13.8.3 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Plyco Bioengineering Co., Ltd. Main Business Overview

13.8.5 Plyco Bioengineering Co., Ltd. Latest Developments

13.9 Ruipu Biopharmaceutical Co., Ltd.

13.9.1 Ruipu Biopharmaceutical Co., Ltd. Company Information

13.9.2 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Offered

13.9.3 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Ruipu Biopharmaceutical Co., Ltd. Main Business Overview

13.9.5 Ruipu Biopharmaceutical Co., Ltd. Latest Developments

13.10 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.

13.10.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information

13.10.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Offered

13.10.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Main Business Overview

13.10.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Latest Developments

14 Research Findings and Conclusion

Table 1. Infectious Bursal Disease Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Infectious Bursal Disease Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Live

Table 4. Major Players of Inactivated

Table 5. Global Infectious Bursal Disease Vaccine Sales by Type (2017-2022) & (K Units)

Table 6. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Infectious Bursal Disease Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Infectious Bursal Disease Vaccine Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Infectious Bursal Disease Vaccine Sales by Application (2017-2022) & (K Units)

Table 11. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Infectious Bursal Disease Vaccine Revenue by Application (2017-2022)

Table 13. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Infectious Bursal Disease Vaccine Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Infectious Bursal Disease Vaccine Sales by Company (2020-2022) & (K Units)

Table 16. Global Infectious Bursal Disease Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Infectious Bursal Disease Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Infectious Bursal Disease Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Infectious Bursal Disease Vaccine Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Infectious Bursal Disease Vaccine Producing Area Distribution and Sales Area

Table 21. Players Infectious Bursal Disease Vaccine Products Offered

Table 22. Infectious Bursal Disease Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Infectious Bursal Disease Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Infectious Bursal Disease Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Infectious Bursal Disease Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Infectious Bursal Disease Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Infectious Bursal Disease Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Infectious Bursal Disease Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Infectious Bursal Disease Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Infectious Bursal Disease Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Infectious Bursal Disease Vaccine Sales by Country (2017-2022) & (K Units)

Table 34. Americas Infectious Bursal Disease Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Infectious Bursal Disease Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Infectious Bursal Disease Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Infectious Bursal Disease Vaccine Sales by Type (2017-2022) & (K Units)

Table 38. Americas Infectious Bursal Disease Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Infectious Bursal Disease Vaccine Sales by Application (2017-2022) & (K Units)

Table 40. Americas Infectious Bursal Disease Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Infectious Bursal Disease Vaccine Sales by Region (2017-2022) & (K Units)

Table 42. APAC Infectious Bursal Disease Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Infectious Bursal Disease Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Infectious Bursal Disease Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Infectious Bursal Disease Vaccine Sales by Type (2017-2022) & (K Units)

Table 46. APAC Infectious Bursal Disease Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Infectious Bursal Disease Vaccine Sales by Application (2017-2022) & (K Units)

Table 48. APAC Infectious Bursal Disease Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Infectious Bursal Disease Vaccine Sales by Country (2017-2022) & (K Units)

Table 50. Europe Infectious Bursal Disease Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Infectious Bursal Disease Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Infectious Bursal Disease Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Infectious Bursal Disease Vaccine Sales by Type (2017-2022) & (K Units)

Table 54. Europe Infectious Bursal Disease Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Infectious Bursal Disease Vaccine Sales by Application (2017-2022) & (K Units)

Table 56. Europe Infectious Bursal Disease Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Infectious Bursal Disease Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Infectious Bursal Disease Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Infectious Bursal Disease Vaccine

Table 66. Key Market Challenges & Risks of Infectious Bursal Disease Vaccine

Table 67. Key Industry Trends of Infectious Bursal Disease Vaccine

Table 68. Infectious Bursal Disease Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Infectious Bursal Disease Vaccine Distributors List

Table 71. Infectious Bursal Disease Vaccine Customer List

Table 72. Global Infectious Bursal Disease Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Infectious Bursal Disease Vaccine Sales Market Forecast by Region

Table 74. Global Infectious Bursal Disease Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Infectious Bursal Disease Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Infectious Bursal Disease Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Infectious Bursal Disease Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Infectious Bursal Disease Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Infectious Bursal Disease Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Infectious Bursal Disease Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Infectious Bursal Disease Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Infectious Bursal Disease Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Infectious Bursal Disease Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Infectious Bursal Disease Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Infectious Bursal Disease Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Infectious Bursal Disease Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Infectious Bursal Disease Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Infectious Bursal Disease Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Infectious Bursal Disease Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Infectious Bursal Disease Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Infectious Bursal Disease Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Zoetis Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Zoetis Infectious Bursal Disease Vaccine Product Offered

Table 94. Zoetis Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Zoetis Main Business

Table 96. Zoetis Latest Developments

Table 97. Merck Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. Merck Infectious Bursal Disease Vaccine Product Offered

Table 99. Merck Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Merck Main Business

Table 101. Merck Latest Developments

Table 102. Elanco Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Elanco Infectious Bursal Disease Vaccine Product Offered

Table 104. Elanco Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Elanco Main Business

Table 106. Elanco Latest Developments

Table 107. Boehringer Ingelheim Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Offered

Table 109. Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Boehringer Ingelheim Main Business

Table 111. Boehringer Ingelheim Latest Developments

Table 112. Ceva Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. Ceva Infectious Bursal Disease Vaccine Product Offered

Table 114. Ceva Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Ceva Main Business

Table 116. Ceva Latest Developments

Table 117. Qingdao Yibang Biological Engineering Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Offered

Table 119. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Qingdao Yibang Biological Engineering Co., Ltd. Main Business

Table 121. Qingdao Yibang Biological Engineering Co., Ltd. Latest Developments

Table 122. Shandong Lvdu Biological Technology Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Offered

Table 124. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Shandong Lvdu Biological Technology Co., Ltd. Main Business

Table 126. Shandong Lvdu Biological Technology Co., Ltd. Latest Developments

Table 127. Plyco Bioengineering Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Offered

Table 129. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Plyco Bioengineering Co., Ltd. Main Business

Table 131. Plyco Bioengineering Co., Ltd. Latest Developments

Table 132. Ruipu Biopharmaceutical Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 133. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Offered

Table 134. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Ruipu Biopharmaceutical Co., Ltd. Main Business

Table 136. Ruipu Biopharmaceutical Co., Ltd. Latest Developments

Table 137. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 138. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Offered

Table 139. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Main Business

Table 141. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Latest Developments

List of Figures

Figure 1. Picture of Infectious Bursal Disease Vaccine

Figure 2. Infectious Bursal Disease Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Infectious Bursal Disease Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Infectious Bursal Disease Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Infectious Bursal Disease Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Live

Figure 10. Product Picture of Inactivated

Figure 11. Global Infectious Bursal Disease Vaccine Sales Market Share by Type in 2021

Figure 12. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Infectious Bursal Disease Vaccine Consumed in Veterinary Pharmacy

Figure 14. Global Infectious Bursal Disease Vaccine Market: Veterinary Pharmacy (2017-2022) & (K Units)

Figure 15. Infectious Bursal Disease Vaccine Consumed in Online Sale

Figure 16. Global Infectious Bursal Disease Vaccine Market: Online Sale (2017-2022) & (K Units)

Figure 17. Infectious Bursal Disease Vaccine Consumed in Others

Figure 18. Global Infectious Bursal Disease Vaccine Market: Others (2017-2022) & (K Units)

Figure 19. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2017-2022)

Figure 20. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application in 2021

Figure 21. Infectious Bursal Disease Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Infectious Bursal Disease Vaccine Revenue Market Share by Company in 2021

Figure 23. Global Infectious Bursal Disease Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Infectious Bursal Disease Vaccine Revenue Market Share by Geographic Region in 2021

Figure 25. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2017-2022)

Figure 26. Global Infectious Bursal Disease Vaccine Revenue Market Share by Country/Region in 2021

Figure 27. Americas Infectious Bursal Disease Vaccine Sales 2017-2022 (K Units)

Figure 28. Americas Infectious Bursal Disease Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. APAC Infectious Bursal Disease Vaccine Sales 2017-2022 (K Units)

Figure 30. APAC Infectious Bursal Disease Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Europe Infectious Bursal Disease Vaccine Sales 2017-2022 (K Units)

Figure 32. Europe Infectious Bursal Disease Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Infectious Bursal Disease Vaccine Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Infectious Bursal Disease Vaccine Revenue 2017-2022 ($ Millions)

Figure 35. Americas Infectious Bursal Disease Vaccine Sales Market Share by Country in 2021

Figure 36. Americas Infectious Bursal Disease Vaccine Revenue Market Share by Country in 2021

Figure 37. United States Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Infectious Bursal Disease Vaccine Sales Market Share by Region in 2021

Figure 42. APAC Infectious Bursal Disease Vaccine Revenue Market Share by Regions in 2021

Figure 43. China Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Infectious Bursal Disease Vaccine Sales Market Share by Country in 2021

Figure 50. Europe Infectious Bursal Disease Vaccine Revenue Market Share by Country in 2021

Figure 51. Germany Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Infectious Bursal Disease Vaccine Revenue Market Share by Country in 2021

Figure 58. Egypt Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Infectious Bursal Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Infectious Bursal Disease Vaccine in 2021

Figure 64. Manufacturing Process Analysis of Infectious Bursal Disease Vaccine

Figure 65. Industry Chain Structure of Infectious Bursal Disease Vaccine

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles